Respiratory

Here are the top 5 articles for the month of October.

Reducing the use of metered-dose inhalers for asthma could shrink the carbon footprint while achieving cost savings if less expensive brands of dry powder inhalers are used, according to new research findings.

This week, the top managed care news included the average Affordable Care Act premiums falling 4%; the FDA approving a triple combination treatment for cystic fibrosis; House Republicans releasing part 1 of their healthcare plan.

Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health, discusses how sleep apnea is a comorbidity for other lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease.

The FDA approved the triple combination of elexacaftor, ivacaftor, and tezacaftor, to be sold under the name Trikafta, as a novel treatment among patients with the most common cystic fibrosis mutation.

Several species of bacteria that can transmit respiratory infections have varying levels of response to the disinfecting agents used in municipal water treatment systems, with no one water disinfection strategy achieving complete microbial control, according to new findings.

African Americans who report high levels of chronic stress were shown to be at a heightened risk of developing high blood pressure, or hypertension, with specific stressors such as discrimination and socioeconomic status serving as possible catalysts, according to study findings.

Long term e-cigarette impact on humans remains unknown, although studies on mice suggest potentially harmful consequences for users.

An in-press study detailed the characteristics of 4 asthma endotypes and their association with asthma-related healthcare outcomes and responsiveness to treatment.

Research presented at the European Respiratory Society Conference 2019 details the novel use of a single inhaler combining 3 therapies, as opposed to 2, in 2 clinical studies on patients with severe asthma.

Pirfenidone was shown to potentially benefit patients with uILD in a phase 2 trial, according to research presented at the European Respiratory Society Congress 2019 in Madrid, Spain.

Adherence to documenting asthma severity or control and providing ample education to patients was low among physicians from 2012-2015, with primary care providers monitoring nearly two-thirds of asthma-related visits, according to a federal report.

Flavored e-cigarettes without nicotine were shown to have differing asthma outcomes on mice based on the flavor, indicating that some flavors may worsen the severity of allergic airways disease, according to a new study.

Individuals with HIV are often susceptible to opportunistic pulmonary infections, but the lung lesions resulting from these infections can be mistaken for lung cancer, according to a new study that aimed to characterize features of OPIs versus tumors in patients with HIV.

The Trump administration said Wednesday that the FDA will “prioritize” enforcement of flavored e-cigarette regulations in an effort to get them removed from the market.

Juul is being investigated for making unauthorized safety claims, while the governor of New York proposes to ban flavored e-cigarettes; Sutter Health is being sued for its role in rising healthcare costs; a European doctor who uses telemedicine and internet prescribing to provide American women with mifepristone and misoprostol to induce abortion in the first trimester is suing the FDA.

School-based telemedicine was shown to potentially enhance healthcare benefits for children with chronic diseases, such as asthma, in rural and medically underserved communities, according to a study.

Oxycontin manufacturer rejects settlement for role in opioid epidemic and moves toward bankruptcy; new vaping-related respiratory illnesses reported; Senator Kamala Harris, D-California, a 2020 presidential candidate, proposes a new healthcare plan for veterans.

E-cigarette vapor exposure, independent nicotine, was shown to alter lipid homeostasis and immunity impairment in mice, warranting further investigation into these vaping solvents.

A ratio of sinus scores calculated based on computed tomography (CT) imaging can accurately predict the recurrence of chronic rhinosinusitis (CRS) with nasal polyps, according to new findings.

Albert Rizzo, MD, FACP, chief medical officer for the American Lung Association, offers his thoughts on the FDA's recent proposal to require health warnings with images on cigarette packages.

Quitting smoking can reduce a heavy smoker’s risk of heart disease within 5 years.

CDC continues to investigate growing cases of lung illnesses for possible correlations to vape usage; a study suggests steroid inhaler use in patients with mild asthma may be ineffective; Oklahoma judge set to decide opioid lawsuit against Johnson & Johnson today.

Researchers found evidence correlating toxic air pollutants to increased respiratory and cardiovascular death rates.

A new study said antimicrobial resistance rates may display seasonal variation, peaking in winter, that could result from the seasonality of infectious diseases and accompanied antibiotic use.

Planned Parenthood's efforts to halt the Trump administraion's "gag rule" have been denied by a federal appeals court; e-cigarette usage is being probed by the CDC for links to reported cases of lung illnesses; public health experts warn that Trump's new administration plan will lead to ailing immigrants.

Parents treated for tobacco addiction within a pediatric office were associated with a significant decline in smoking rates as opposed to standard offices.

Under a proposed rule released today, the agency would require new health warnings on cigarette packages and advertisements, which would feature pictures and images depicting some of the lesser-known health risks, including bladder cancer and heart disease.

The FDA ordered 4 companies to stop selling 44 of their flavored e-liquid and hookah tobacco products that lack the required approval for sale; CMS has yet to implement a 2014 law preventing unnecessary, expensive screening tests (magnetic resonance imaging, computed tomagraphy scans and other tests) that could harm patients and waste resources; Amarin, which is seeking FDA approval for an expansion of Vascepa labeling to include data that showed a 25% reduction in the risk of heart attacks and strokes, said the FDA has scheduled an advisory committee meeting for November 14.

Through the study, researchers identified a potential treatment target that could lead to alternatives for preventing the life-threatening condition.